spacer
spacer

PDBsum entry 1t5x

Go to PDB code: 
protein Protein-protein interface(s) links
Immune system PDB id
1t5x
Jmol
Contents
Protein chains
179 a.a. *
190 a.a. *
13 a.a. *
230 a.a. *
Waters ×221
* Residue conservation analysis
PDB id:
1t5x
Name: Immune system
Title: Hla-dr1 in complex with a synthetic peptide (aaysdqatplllspr) and the superantigen sec3-3b2
Structure: Hla class ii histocompatibility antigen, dr alpha chain. Chain: a. Fragment: extracellular domain. Synonym: mhc class ii antigen dra. Engineered: yes. Hla class ii histocompatibility antigen, drb1-1 beta chain. Chain: b.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: hla-dra 0101. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Gene: hla-drb1 0101. Synthetic: yes. Other_details: synthetic peptide desinged to study the p10
Biol. unit: Dodecamer (from PQS)
Resolution:
2.50Å     R-factor:   0.208     R-free:   0.241
Authors: Z.Zavala-Ruiz,I.Strug,M.W.Anderson,J.Gorski,L.J.Stern
Key ref:
Z.Zavala-Ruiz et al. (2004). A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins. Chem Biol, 11, 1395-1402. PubMed id: 15489166 DOI: 10.1016/j.chembiol.2004.08.007
Date:
05-May-04     Release date:   17-Aug-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P01903  (DRA_HUMAN) -  HLA class II histocompatibility antigen, DR alpha chain
Seq:
Struc:
254 a.a.
179 a.a.
Protein chain
Pfam   ArchSchema ?
P04229  (2B11_HUMAN) -  HLA class II histocompatibility antigen, DRB1-1 beta chain
Seq:
Struc:
266 a.a.
190 a.a.
Protein chain
Pfam   ArchSchema ?
P27705  (MIG1_YEAST) -  Regulatory protein MIG1
Seq:
Struc:
504 a.a.
13 a.a.*
Protein chain
Pfam   ArchSchema ?
P0A0L5  (ENTC3_STAAU) -  Enterotoxin type C-3
Seq:
Struc:
266 a.a.
230 a.a.*
Key:    PfamA domain  PfamB domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 10 residue positions (black crosses)

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     extracellular region   3 terms 
  Biological process     immune response   3 terms 

 

 
DOI no: 10.1016/j.chembiol.2004.08.007 Chem Biol 11:1395-1402 (2004)
PubMed id: 15489166  
 
 
A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
Z.Zavala-Ruiz, I.Strug, M.W.Anderson, J.Gorski, L.J.Stern.
 
  ABSTRACT  
 
Peptides bind to class II major histocompatibility complex (MHC) proteins in an extended conformation. Pockets in the peptide binding site spaced to accommodate peptide side chains at the P1, P4, P6, and P9 positions have been previously characterized and help to explain the obtained peptide binding specificity. However, two peptides differing only at P10 have significantly different binding affinities for HLA-DR1. The structure of HLA-DR1 in complex with the tighter binding peptide shows that the peptide binds in the usual polyproline type II conformation, but with the P10 residue accommodated in a shallow pocket at the end of the binding groove. HLA-DR1 variants with polymorphic residues at these positions were produced and found to exhibit different side chain specificity at the P10 position. These results define a new specificity position in HLA-DR proteins.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. The P10 Position of Peptides Can Affect Binding to HLA-DR1(A) Surface of the HLA-DR1 peptide binding site with bound AAYSDQATPLLLSPR peptide shown as a stick model. In the peptide, carbon atoms are yellow, nitrogen atoms are blue, and oxygen atoms are red. Peptide side chain binding pockets are labeled.(B) Competitive binding analysis of two peptides that differ only in the P10 position. A fixed concentration of peptide-free HLA-DR1 and biotinylated Ha peptide was incubated with increasing concentrations of either AAYSDQATPLLLSPR or AAYSDQATPLLGSPR peptide. After binding for 3 days at 37°C, the amount of biotinylated Ha peptide/HLA-DR1 complexes was measured with alkaline phosphatase-labeled streptavidin in an antibody-capture assay.
Figure 2.
Figure 2. Crystal Structure of HLA-DR1 Bound to AAYSDQATPLLLSPR(A) 2Fo-Fc electron density map contoured at 1σ using data in the resolution rage of 30–2.4 Å, with all peptide atoms omitted from the map calculation. The peptide carbon atoms are yellow, and nitrogen and oxygen atoms are blue and red, respectively.(B) The AAYSDQATPLLLSPR peptide from the HLA-DR1/SEC3-3B2 complex (carbon atoms colored in yellow) was superimposed with the peptides present in the structure of HLA-DR1 without the superantigen (carbon atoms colored in green or magenta for the two molecules in the asymmetric unit).(C) 2Fo-Fc electron density maps contoured at 1σ for the P10 region of HLA-DR1/AAYSDQATPLLLSPR. (All the labeled residues were omitted from the map calculation). The carbon atoms for the peptide are yellow, and the ones for HLA-DR1 are green. The view is from the right side of (A), with the α subunit helix to the right and the β subunit helix to the left.(D) Surface of the HLA-DR1 P10 region shown with the same view as (C). Residues lining the pocket are labeled. Residues β57 and β60 are polymorphic among HLA-DR proteins. Figures were generated with PyMol [43].
 
  The above figures are reprinted by permission from Cell Press: Chem Biol (2004, 11, 1395-1402) copyright 2004.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20007533 C.K.Baumgartner, A.Ferrante, M.Nagaoka, J.Gorski, and L.P.Malherbe (2010).
Peptide-MHC class II complex stability governs CD4 T cell clonal selection.
  J Immunol, 184, 573-581.  
20139279 J.Sidney, A.Steen, C.Moore, S.Ngo, J.Chung, B.Peters, and A.Sette (2010).
Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.
  J Immunol, 184, 2492-2503.  
20661469 S.Ling, A.Cheng, P.Pumpens, M.Michalak, and J.Holoshitz (2010).
Identification of the rheumatoid arthritis shared epitope binding site on calreticulin.
  PLoS One, 5, e11703.  
18545669 C.A.Painter, A.Cruz, G.E.López, L.J.Stern, and Z.Zavala-Ruiz (2008).
Model for the peptide-free conformation of class II MHC proteins.
  PLoS ONE, 3, e2403.  
18925947 C.S.Parry (2008).
Flanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pockets.
  BMC Struct Biol, 8, 44.  
17937498 J.M.Calvo-Calle, I.Strug, M.D.Nastke, S.P.Baker, and L.J.Stern (2007).
Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection.
  PLoS Pathog, 3, 1511-1529.  
16565072 C.Parra-López, J.M.Calvo-Calle, T.O.Cameron, L.E.Vargas, L.M.Salazar, M.E.Patarroyo, E.Nardin, and L.J.Stern (2006).
Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein.
  J Biol Chem, 281, 14907-14917.  
17105666 J.Salomon, and D.R.Flower (2006).
Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores.
  BMC Bioinformatics, 7, 501.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.